Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ResQ Family: Impact of Respiratory Syncytial Virus (RSV) Hospitalisation on Quality of Life of Families - A Multi-Country Study

NCT05550545 is registered in ClinicalTrials.gov with Global Foundation for the Care of Newborn Infants as lead sponsor.

NCT NCT05550545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05550545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ResQ Family: Impact of Respiratory Syncytial Virus (RSV) Hospitalisation on Quality of Life of Families - A Multi-Country Study
Lead sponsor
Global Foundation for the Care of Newborn Infants
Phase
Observational
Overall status
Unknown status
Start date
September 29, 2022
Completion date
June 30, 2024
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

caregiver burden, family, infant all, quality of life, rsv infection